This redistribution of tau expression is consistent with results reported in other neurodegenerative diseases, including Alzheimer’s disease, in which tau proteins translocate from axons to the soma of nerve cells, impairing axonal transport and contributing to neuronal dysfunction [22]. Here, MAPT is linked to neurodegenerative disease.